CLINICAL_TRIALS
trial_result
· 2014-04-17
Clinical Trial Update: Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
Summary
This document reports the completed re-examination study of the sitagliptin/metformin combination JANUMET (0431A-182), with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2014-04-17